These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12391283)

  • 1. Purinergic P2X(2) receptor desensitization depends on coupling between ectodomain and C-terminal domain.
    He ML; Koshimizu TA; Tomić M; Stojilkovic SS
    Mol Pharmacol; 2002 Nov; 62(5):1187-97. PubMed ID: 12391283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of purinergic P2X receptor activity on ectodomain structure.
    He ML; Zemkova H; Stojilkovic SS
    J Biol Chem; 2003 Mar; 278(12):10182-8. PubMed ID: 12524445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains.
    Koshimizu TA; Ueno S; Tanoue A; Yanagihara N; Stojilkovic SS; Tsujimoto G
    J Biol Chem; 2002 Dec; 277(49):46891-9. PubMed ID: 12361958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional characterization of human P2X(2) receptors.
    Lynch KJ; Touma E; Niforatos W; Kage KL; Burgard EC; van Biesen T; Kowaluk EA; Jarvis MF
    Mol Pharmacol; 1999 Dec; 56(6):1171-81. PubMed ID: 10570044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of the C-terminal domain to the control of P2X receptor desensitization.
    Koshimizu T; Koshimizu M; Stojilkovic SS
    J Biol Chem; 1999 Dec; 274(53):37651-7. PubMed ID: 10608821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation.
    Sokolova E; Skorinkin A; Fabbretti E; Masten L; Nistri A; Giniatullin R
    Br J Pharmacol; 2004 Mar; 141(6):1048-58. PubMed ID: 14980981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.
    Gerevich Z; Zadori Z; Müller C; Wirkner K; Schröder W; Rubini P; Illes P
    Br J Pharmacol; 2007 May; 151(2):226-36. PubMed ID: 17351651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of three P2X(2) receptor splice variants from guinea pig cochlea.
    Chen C; Parker MS; Barnes AP; Deininger P; Bobbin RP
    J Neurophysiol; 2000 Mar; 83(3):1502-9. PubMed ID: 10712475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors.
    Zemkova H; He ML; Koshimizu TA; Stojilkovic SS
    J Neurosci; 2004 Aug; 24(31):6968-78. PubMed ID: 15295032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells.
    Koshimizu TA; Van Goor F; Tomić M; Wong AO; Tanoue A; Tsujimoto G; Stojilkovic SS
    Mol Pharmacol; 2000 Nov; 58(5):936-45. PubMed ID: 11040040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of negative residues in the P2X3 ATP receptor ectodomain as structural determinants for desensitization and the Ca2+-sensing modulatory sites.
    Fabbretti E; Sokolova E; Masten L; D'Arco M; Fabbro A; Nistri A; Giniatullin R
    J Biol Chem; 2004 Dec; 279(51):53109-15. PubMed ID: 15475563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate.
    Yan Z; Liang Z; Obsil T; Stojilkovic SS
    J Biol Chem; 2006 Oct; 281(43):32649-59. PubMed ID: 16954225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors.
    Gomes DA; Song Z; Stevens W; Sladek CD
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R940-9. PubMed ID: 19625689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors.
    Asatryan L; Popova M; Woodward JJ; King BF; Alkana RL; Davies DL
    Neuropharmacology; 2008 Oct; 55(5):835-43. PubMed ID: 18639563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of zinc on human and rat P2X2 receptors.
    Tittle RK; Hume RI
    J Neurosci; 2008 Oct; 28(44):11131-40. PubMed ID: 18971456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes.
    Inoue K; Denda M; Tozaki H; Fujishita K; Koizumi S; Inoue K
    J Invest Dermatol; 2005 Apr; 124(4):756-63. PubMed ID: 15816834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species potentiate the P2X2 receptor activity through intracellular Cys430.
    Coddou C; Codocedo JF; Li S; Lillo JG; Acuña-Castillo C; Bull P; Stojilkovic SS; Huidobro-Toro JP
    J Neurosci; 2009 Sep; 29(39):12284-91. PubMed ID: 19793987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.
    Fang KM; Yang CS; Sun SH; Tzeng SF
    J Neurochem; 2009 Dec; 111(5):1225-37. PubMed ID: 19860838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of recombinant human and rat P2X receptor subtypes.
    Bianchi BR; Lynch KJ; Touma E; Niforatos W; Burgard EC; Alexander KM; Park HS; Yu H; Metzger R; Kowaluk E; Jarvis MF; van Biesen T
    Eur J Pharmacol; 1999 Jul; 376(1-2):127-38. PubMed ID: 10440098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved lysin and arginin residues in the extracellular loop of P2X(3) receptors are involved in agonist binding.
    Fischer W; Zadori Z; Kullnick Y; Gröger-Arndt H; Franke H; Wirkner K; Illes P; Mager PP
    Eur J Pharmacol; 2007 Dec; 576(1-3):7-17. PubMed ID: 17764672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.